IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). (Q40438269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Rury Holman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

G F Bottazzo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

E Bosi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C A Cull

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M Locatelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P Zimmet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

I R Mackay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

1 reference

12 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

703-708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15765222%20AND%20SRC:MED&resulttype=core&format=json

Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM

9 January 2020

cites work

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance

1 reference

12 December 2020

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

1 reference

12 December 2020

IA-2 and IA-2beta: the immune response in IDDM.

1 reference

12 December 2020

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

1 reference

12 December 2020

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

12 December 2020

Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The World Health Organization International Collaborative Study for islet cell antibodies

1 reference

12 December 2020

Diabetes epidemiology as a tool to trigger diabetes research and care

1 reference

12 December 2020

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

12 December 2020

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects

1 reference

12 December 2020

IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.

1 reference

12 December 2020

Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.

1 reference

12 December 2020

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

12 December 2020

A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q

1 reference

12 December 2020

Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020